Your browser doesn't support javascript.
loading
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Fernández Sánchez, Manuel; Visnová, Hana; Larsson, Per; Yding Andersen, Claus; Filicori, Marco; Blockeel, Christophe; Pinborg, Anja; Khalaf, Yacoub; Mannaerts, Bernadette.
Afiliação
  • Fernández Sánchez M; IVI-RMA Seville, Seville, Spain.
  • Visnová H; Departament of Surgery, Universidad de Sevilla, Seville, Spain.
  • Larsson P; Department of Molecular Biology and Biochemical Engineering, Universidad Pablo de Olavide, Seville, Spain.
  • Yding Andersen C; Fundacion IVI, Instituto Investigación Sanitaria La Fe, Valencia, Spain.
  • Filicori M; IVF CUBE, Prague, Czech Republic.
  • Blockeel C; Global Biometrics, Ferring Pharmaceuticals, Copenhagen, Denmark.
  • Pinborg A; Laboratory of Reproductive Biology, Copenhagen University Hospital and Faculty of Health Science, Copenhagen University, Copenhagen, Denmark.
  • Khalaf Y; GynePro Medical Group, Bologna, Italy.
  • Mannaerts B; Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Hum Reprod ; 37(6): 1161-1174, 2022 05 30.
Article em En | MEDLINE | ID: mdl-35451013

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Indução da Ovulação / Hormônio Foliculoestimulante Humano Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Indução da Ovulação / Hormônio Foliculoestimulante Humano Idioma: En Ano de publicação: 2022 Tipo de documento: Article